BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-418@pharmaconomics
DTSTAMP:20260707T041757Z
DTSTART;VALUE=DATE:20260130
DTEND;VALUE=DATE:20260131
SUMMARY:AQST CRL — Anaphylm
DESCRIPTION:An FDA complete response letter on Anaphylm for Type I allergic reactions\, including anaphylaxis is in focus around Jan 30\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1398733/000139873326000016/q42025supplementalearnin.htm\n\nTrack it: https://pharmaconomics.com/e/418
URL:https://pharmaconomics.com/e/418
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AQST catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR